These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38342403)

  • 1. Plaque Morphological Changes in Femoropopliteal Arterial Lesions Caused by Balloon Angioplasty: Analysis Through Integrated Backscatter Intravascular Ultrasound.
    Hayashi O; Shimada T; Fujisawa N; Yamazaki T; Izumiya Y; Fukuda D
    Eur J Vasc Endovasc Surg; 2024 Jul; 68(1):133-134. PubMed ID: 38342403
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World.
    Böhme T; Noory E; Beschorner U; Jacques B; Bürgelin K; Macharzina R; Gebauer E; Cheung F; Lechner P; Nührenberg T; Zeller T
    JACC Cardiovasc Interv; 2020 Sep; 13(17):2052-2061. PubMed ID: 32593696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
    Aihara H; Higashitani M; Takimura H; Tobita K; Jujo K; Hozawa K; Yamaguchi T; Iwata Y; Tokuyama H; Sakurai M; Murata N; Fujimoto Y; Kikuchi A; Koganei H; Sato A; Noguchi Y; Ieda M
    Circ J; 2020 Jul; 84(8):1320-1329. PubMed ID: 32581151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: intravascular ultrasound for femoropopliteal stenting: can it predict outcomes with current-generation stents?
    Foley TR; Armstrong EJ
    J Endovasc Ther; 2015 Jun; 22(3):350-1. PubMed ID: 25904483
    [No Abstract]   [Full Text] [Related]  

  • 7. Orbital Atherectomy Plaque Modification Assessment of the Femoropopliteal Artery Via Intravascular Ultrasound (TRUTH Study).
    Babaev A; Zavlunova S; Attubato MJ; Martinsen BJ; Mintz GS; Maehara A
    Vasc Endovascular Surg; 2015 Oct; 49(7):188-94. PubMed ID: 26490645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
    J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
    Zeller T; Lopez L; Pigott JP
    J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials.
    Anantha-Narayanan M; Shah SM; Jelani QU; Garcia S; Ionescu C; Regan C; Mena-Hurtado C
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):139-148. PubMed ID: 30838719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Sirolimus- vs. paCLitaxEl-coated balloon angioPlasty In atherosclerotic femoropopliteal lesiOnS (ASCLEPIOS Study): preliminary results.
    Taneva GT; Pitoulias GA; Abu Bakr N; Kazemtash M; Muñoz Castellanos J; Donas KP
    J Cardiovasc Surg (Torino); 2022 Feb; 63(1):8-12. PubMed ID: 35179337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of paclitaxel-coated balloon angioplasty with femoropopliteal bypass surgery in treating femoropopliteal lesions.
    Kavala AA; Kuserli Y; Turkyilmaz S
    Vascular; 2021 Apr; 29(2):260-269. PubMed ID: 32838692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Guidewire Route on Severe Dissection After Balloon Angioplasty for Femoropopliteal Chronic Total Occlusion Lesions: An Intravascular Ultrasound Analysis.
    Shimada T; Shima Y; Miura K; Shimizu H; Takamatsu M; Ikuta A; Habara S; Tanaka H; Goto T; Kadota K
    Eur J Vasc Endovasc Surg; 2021 May; 61(5):830-836. PubMed ID: 33632611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial.
    Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; Sixt S; Brucks S; Beschorner U; Klumb CT; Thieme M;
    EuroIntervention; 2020 Apr; 15(18):e1633-e1640. PubMed ID: 31687933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed stenosis regression after drug-coated balloon angioplasty for femoropopliteal artery lesions.
    Shimada T; Shima Y; Takahashi K; Miura K; Takamatsu M; Ikuta A; Habara S; Tanaka H; Goto T; Izumiya Y; Kadota K
    Heart Vessels; 2022 May; 37(5):730-737. PubMed ID: 34674001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular elastography: a novel method to characterize occluded lower limb arteries prior to endovascular therapy.
    Takimura H; Hirano K; Muramatsu T; Tsukahara R; Ito Y; Sakai T; Ishimori H; Nakano M; Yamawaki M; Araki M; Kato T; Kobayashi N; Sakamoto Y; Ishii A; Takama T; Tokuda T
    J Endovasc Ther; 2014 Oct; 21(5):654-61. PubMed ID: 25290793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
    Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directional versus orbital atherectomy of femoropopliteal artery lesions: Angiographic and intravascular ultrasound outcomes.
    Babaev A; Halista M; Bakirova Z; Avtushka V; Matsumura M; Maehara A
    Catheter Cardiovasc Interv; 2022 Oct; 100(4):687-695. PubMed ID: 35842776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.